Keith A. Katkin

Keith A. Katkin

DirectoratSyndax Pharmaceuticals· In proxies 2023–2025

Keith A. Katkin sits on 7 public boards.

Boards1

  • Syndax PharmaceuticalsDirector · 8 yr on the boardIndependentAudit, Compensation (Chair), Nominating and Corporate Governance, Science and Technology—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Syndax PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -39%
  2. Emergent BioSolutionsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Eledon PharmaceuticalsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrNo stock prices for these years
  4. Ambros TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  5. Eledon Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Emergent BioSolutions, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Rigel Pharmaceuticals Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?